<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Berg AT</submitter><funding>NINDS NIH HHS</funding><pagination>863-871</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5710404</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>171(9)</volume><pubmed_abstract>&lt;h4>Importance&lt;/h4>Early-life epilepsies are often a consequence of numerous neurodevelopmental disorders, most of which are proving to have genetic origins. The role of genetic testing in the initial evaluation of these epilepsies is not established.&lt;h4>Objective&lt;/h4>To provide a contemporary account of the patterns of use and diagnostic yield of genetic testing for early-life epilepsies.&lt;h4>Design, setting, and participants&lt;/h4>In this prospective cohort, children with newly diagnosed epilepsy with an onset at less than 3 years of age were recruited from March 1, 2012, to April 30, 2015, from 17 US pediatric hospitals and followed up for 1 year. Of 795 families approached, 775 agreed to participate. Clinical diagnosis of the etiology of epilepsy were characterized based on information av</pubmed_abstract><journal>JAMA pediatrics</journal><pubmed_title>Early-Life Epilepsies and the Emerging Role of Genetic Testing.</pubmed_title><pmcid>PMC5710404</pmcid><funding_grant_id>K23 NS092923</funding_grant_id><funding_grant_id>R21 NS094999</funding_grant_id><funding_grant_id>R01 NS092772</funding_grant_id><funding_grant_id>R01 NS073768</funding_grant_id><funding_grant_id>K12 NS066274</funding_grant_id><pubmed_authors>Saneto RP</pubmed_authors><pubmed_authors>Knupp KG</pubmed_authors><pubmed_authors>Kossoff EH</pubmed_authors><pubmed_authors>Novotny EJ</pubmed_authors><pubmed_authors>Koh S</pubmed_authors><pubmed_authors>Gaillard WD</pubmed_authors><pubmed_authors>Shellhaas RA</pubmed_authors><pubmed_authors>Ryan N</pubmed_authors><pubmed_authors>Kekis M</pubmed_authors><pubmed_authors>Dobyns WB</pubmed_authors><pubmed_authors>Grinspan ZM</pubmed_authors><pubmed_authors>Berg AT</pubmed_authors><pubmed_authors>Alexander JJ</pubmed_authors><pubmed_authors>Coryell J</pubmed_authors><pubmed_authors>Mytinger JR</pubmed_authors><pubmed_authors>Wusthoff C</pubmed_authors><pubmed_authors>Chu CJ</pubmed_authors><pubmed_authors>Sullivan JE</pubmed_authors><pubmed_authors>Keator C</pubmed_authors><pubmed_authors>Loddenkemper T</pubmed_authors><pubmed_authors>Wirrell EC</pubmed_authors><pubmed_authors>Valencia I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Early-Life Epilepsies and the Emerging Role of Genetic Testing.</name><description>&lt;h4>Importance&lt;/h4>Early-life epilepsies are often a consequence of numerous neurodevelopmental disorders, most of which are proving to have genetic origins. The role of genetic testing in the initial evaluation of these epilepsies is not established.&lt;h4>Objective&lt;/h4>To provide a contemporary account of the patterns of use and diagnostic yield of genetic testing for early-life epilepsies.&lt;h4>Design, setting, and participants&lt;/h4>In this prospective cohort, children with newly diagnosed epilepsy with an onset at less than 3 years of age were recruited from March 1, 2012, to April 30, 2015, from 17 US pediatric hospitals and followed up for 1 year. Of 795 families approached, 775 agreed to participate. Clinical diagnosis of the etiology of epilepsy were characterized based on information av</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Sep</publication><modification>2026-05-02T18:45:14.594Z</modification><creation>2019-03-26T23:54:22Z</creation></dates><accession>S-EPMC5710404</accession><cross_references><pubmed>28759667</pubmed><doi>10.1001/jamapediatrics.2017.1743</doi></cross_references></HashMap>